Cutler Group LLC / CA - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 1 filers reported holding CLOVIS ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cutler Group LLC / CA ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2022$49,000
-47.9%
51,969
-46.4%
0.00%
-57.1%
Q2 2022$94,000
-58.6%
97,023
-44.2%
0.01%
-41.7%
Q1 2022$227,000173,819
+57839.7%
0.01%
Q1 2021$0
-100.0%
300
-97.8%
0.00%
-100.0%
Q4 2020$46,000
-52.1%
13,700
-54.8%
0.00%
-66.7%
Q3 2020$96,000
+1.1%
30,300
+65.6%
0.01%0.0%
Q2 2020$95,000
-34.9%
18,300
-34.9%
0.01%
-25.0%
Q1 2020$146,000
-54.9%
28,100
-64.6%
0.01%
-60.0%
Q4 2019$324,000
+32300.0%
79,300
+1001.4%
0.02%
Q3 2019$1,000
-90.0%
7,200
-51.0%
0.00%
-100.0%
Q2 2019$10,000
-56.5%
14,700
-40.5%
0.00%
-50.0%
Q1 2019$23,000
-90.7%
24,700
-58.4%
0.00%
-91.3%
Q4 2018$247,000
-63.1%
59,328
-9.0%
0.02%
-50.0%
Q3 2018$670,000
-35.1%
65,200
-10.7%
0.05%
-43.9%
Q2 2018$1,033,000
-37.6%
73,000
-27.6%
0.08%
-42.3%
Q1 2018$1,656,000
-31.2%
100,800
-39.4%
0.14%
+43.4%
Q4 2017$2,406,000
-17.2%
166,423
-18.8%
0.10%
-9.2%
Q3 2017$2,906,000
-46.0%
204,849
-26.8%
0.11%
-45.2%
Q2 2017$5,378,000
+104.3%
279,983
+65.6%
0.20%
+82.6%
Q1 2017$2,633,000
-45.9%
169,077
-33.7%
0.11%
-37.7%
Q4 2016$4,870,000
+375.6%
255,117
+26.8%
0.18%
+288.9%
Q3 2016$1,024,000
+116.0%
201,238
+165.2%
0.04%
+87.5%
Q2 2016$474,000
-79.9%
75,870
-61.2%
0.02%
-84.5%
Q1 2016$2,355,000
-3.2%
195,683
+33.8%
0.16%
+14.0%
Q4 2015$2,432,000146,2370.14%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q3 2023
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,997,826$10,834,0000.69%
Ikarian Capital, LLC 1,112,669$3,016,0000.45%
Versant Venture Management, LLC 101,855$276,0000.15%
Virtus ETF Advisers LLC 60,836$165,0000.06%
EMFO, LLC 21,500$58,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
QVT Financial LP 505,000$1,369,0000.05%
PINNACLE ASSOCIATES LTD 706,336$1,914,0000.03%
XTX Topco Ltd 20,920$57,0000.03%
State of Wyoming 25,419$69,0000.03%
View complete list of CLOVIS ONCOLOGY INC shareholders